Glucose Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2016	FY 2015	FY 2014
Period Ending	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Revenue	1.11	0.95	0.48	0.31	0	0
Revenue Growth	-	98.39%	53.47%	7232.14%	55.97%	1122.77%
Cost of Revenue	1	0.96	0.83	0.29	0	0.02
Gross Profit	0.11	-0	-0.35	0.02	0	-0.02
Selling, General & Admin	0.46	0.32	0.27	0.1	0.12	0.52
Research & Development	-	-	-	-	0	0
Operating Expenses	0.47	0.33	0.27	0.11	0.16	0.52
Operating Income	-0.36	-0.34	-0.62	-0.09	-0.16	-0.55
Interest Expense	-	-0	-0.02	-0.32	-0.12	-0.11
Other Non Operating Income (Expenses)	-	-	0.16	-	-	-
EBT Excluding Unusual Items	-0.36	-0.34	-0.48	-0.41	-0.28	-0.65
Other Unusual Items	-	-	0	-	0.01	-0.01
Pretax Income	-0.36	-0.34	-0.48	-0.41	-0.27	-0.67
Net Income	-0.36	-0.34	-0.48	-0.41	-0.27	-0.67
Net Income to Common	-0.36	-0.34	-0.48	-0.41	-0.27	-0.67
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	14	13	11	3	2	1
Shares Outstanding (Diluted)	14	13	11	3	2	1
Shares Change	-	12.30%	310.45%	42.80%	189.77%	127.15%
EPS (Basic)	-0.03	-0.03	-0.04	-0.15	-0.14	-0.99
EPS (Diluted)	-0.03	-0.03	-0.04	-0.15	-0.14	-0.99
EPS Growth	-	-	-	-	-	-
Gross Margin	10.12%	-0.25%	-73.04%	6.12%	9.29%	-
Operating Margin	-31.99%	-35.24%	-129.88%	-27.66%	-3655.74%	-19905.66%
Profit Margin	-32.09%	-35.54%	-99.37%	-131.04%	-6228.09%	-24439.90%
EBITDA	-	-0.34	-0.62	-0.09	-	-
EBITDA Margin	-	-35.24%	-129.87%	-27.64%	-	-
D&A For EBITDA	-	0	0	0	-	-
EBIT	-0.36	-0.34	-0.62	-0.09	-0.16	-0.55
EBIT Margin	-31.99%	-35.24%	-129.88%	-27.66%	-	-
Advertising Expenses	-	0.4	0.13	-	-	-